(ABX) Abacus Global Management - Overview
Sector: Financial Services | Industry: Insurance - Life | Exchange: NASDAQ (USA) | Market Cap: 867m USD | Total Return: 21.6% in 12m
Avg Turnover: 4.99M
Qual. Beats: 0
Rev. Trend: 97.6%
Warnings
Choppy
Tailwinds
Idiosyncratic Leader, Confidence
Abacus Global Management, Inc. (NASDAQ: ABX) is an international alternative asset manager and market maker specializing in the life insurance settlement industry. The company operates through three primary segments: Asset Management, Life Solutions, and Technology Services. Its business model focuses on the acquisition of life insurance policies from original owners and the subsequent management of these assets for institutional and individual investors.
The life settlement sector bridges the gap between the insurance and capital markets by providing liquidity to policyholders while offering investors non-correlated alternative assets. Abacus leverages proprietary technology to provide mortality verification and data services, which are critical for risk assessment in the secondary insurance market. Formerly known as Abacus Life, Inc., the firm rebranded in February 2025 to reflect its diversified global operations and technology-driven service suite.
Investors can further evaluate the companys valuation metrics and historical performance by reviewing the latest data on ValueRay. Founded in 2004 and headquartered in Orlando, Florida, the company distributes its products through a multi-channel network including financial advisors, direct-to-consumer platforms, and professional intermediaries.
- Expansion of life settlement portfolio drives recurring asset management fee revenue
- Rising interest rates increase cost of capital for insurance policy acquisitions
- Regulatory changes in life settlement markets impact cross-border transaction volume
- Proprietary mortality verification technology adoption improves margins in services segment
- Consumer demand for liquidity fuels volume of original policy owner settlements
| Net Income: 39.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 47.11 > 1.0 |
| NWC/Revenue: -28.43% < 20% (prev -51.52%; Δ 23.09% < -1%) |
| CFO/TA 0.15 > 3% & CFO 127.6m > Net Income 39.2m |
| Net Debt (316.4m) to EBITDA (113.5m): 2.79 < 3 |
| Current Ratio: 0.52 > 1.5 & < 3 |
| Outstanding Shares: last quarter (99.5m) vs 12m ago 2.10% < -2% |
| Gross Margin: 70.80% > 18% (prev 0.88%; Δ 6.99k% > 0.5%) |
| Asset Turnover: 29.71% > 50% (prev 15.71%; Δ 14.00% > 0%) |
| Interest Coverage Ratio: 2.41 > 6 (EBITDA TTM 113.5m / Interest Expense TTM 39.6m) |
| A: -0.09 (Total Current Assets 77.4m - Total Current Liabilities 148.6m) / Total Assets 829.8m |
| B: -0.04 (Retained Earnings -34.5m / Total Assets 829.8m) |
| C: 0.11 (EBIT TTM 95.7m / Avg Total Assets 843.2m) |
| D: -0.08 (Book Value of Equity -34.4m / Total Liabilities 407.2m) |
| Altman-Z'' = -0.02 = B |
| DSRI: 1.34 (Receivables 40.2m/16.1m, Revenue 250.5m/134.6m) |
| GMI: 1.25 (GM 70.80% / 88.29%) |
| AQI: 0.97 (AQ_t 0.89 / AQ_t-1 0.92) |
| SGI: 1.86 (Revenue 250.5m / 134.6m) |
| TATA: -0.11 (NI 39.2m - CFO 127.6m) / TA 829.8m) |
| Beneish M = -2.03 (Cap -4..+1) = BB |
As of June 01, 2026, the stock is trading at USD 8.98 with a total of 375,033 shares traded.
Over the past week, the price has changed by +0.11%,
over one month by -5.47%,
over three months by -6.07% and
over the past year by +21.63%.
Abacus Global Management has no consensus analysts rating.
P/E Trailing = 23.7895
P/E Forward = 10.5708
P/S = 3.4618
P/B = 2.0765
Revenue TTM = 250.5m USD
EBIT TTM = 95.7m USD
EBITDA TTM = 113.5m USD
Long Term Debt = 328.5m USD (from longTermDebt, last quarter)
Short Term Debt = 3.83m USD (from shortTermDebt, last quarter)
Debt = 353.6m USD (from shortLongTermDebtTotal, last quarter) + Leases 11.3m
Net Debt = 316.4m USD (calculated: Debt 353.6m - CCE 37.2m)
Enterprise Value = 1.18b USD (867.1m + Debt 353.6m - CCE 37.2m)
Interest Coverage Ratio = 2.41 (Ebit TTM 95.7m / Interest Expense TTM 39.6m)
EV/FCF = 9.39x (Enterprise Value 1.18b / FCF TTM 126.0m)
FCF Yield = 10.65% (FCF TTM 126.0m / Enterprise Value 1.18b)
FCF Margin = 50.31% (FCF TTM 126.0m / Revenue TTM 250.5m)
Net Margin = 15.63% (Net Income TTM 39.2m / Revenue TTM 250.5m)
Gross Margin = 70.80% ((Revenue TTM 250.5m - Cost of Revenue TTM 73.1m) / Revenue TTM)
Gross Margin QoQ = 76.13% (prev 37.06%)
Tobins Q-Ratio = 1.43 (Enterprise Value 1.18b / Total Assets 829.8m)
Interest Expense / Debt = 11.21% (Interest Expense 39.6m / Debt 353.6m)
Taxrate = 34.28% (3.79m / 11.1m)
NOPAT = 62.9m (EBIT 95.7m * (1 - 34.28%))
Current Ratio = 0.52 (Total Current Assets 77.4m / Total Current Liabilities 148.6m)
Debt / Equity = 0.84 (Debt 353.6m / totalStockholderEquity, last quarter 422.6m)
Debt / EBITDA = 2.79 (Net Debt 316.4m / EBITDA 113.5m)
Debt / FCF = 2.51 (Net Debt 316.4m / FCF TTM 126.0m)
Total Stockholder Equity = 425.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.64% (Net Income 39.2m / Total Assets 829.8m)
RoE = 8.51% (Net Income TTM 39.2m / Total Stockholder Equity 460.0m)
RoCE = 12.14% (EBIT 95.7m / Capital Employed (Equity 460.0m + L.T.Debt 328.5m))
RoIC = 7.57% (NOPAT 62.9m / Invested Capital 830.8m)
WACC = 6.89% (E(867.1m)/V(1.22b) * Re(6.70%) + D(353.6m)/V(1.22b) * Rd(11.21%) * (1-Tc(0.34)))
Discount Rate = 6.70% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 82.22 | Cagr: 24.87%
[DCF] Terminal Value 75.44% ; FCFF base≈126.0m ; Y1≈126.5m ; Y5≈134.0m
[DCF] Fair Price = 18.44 (EV 2.08b - Net Debt 316.4m = Equity 1.77b / Shares 95.9m; r=8.35% [WACC [floored]]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.04 | # QB: 0
Revenue Correlation: 97.65 | Revenue CAGR: 108.7% | SUE: N/A | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.24 | Chg30d=+1.55% | Revisions=+14% | Analysts=6
EPS next Quarter (2026-09-30): EPS=0.27 | Chg30d=+7.20% | Revisions=+50% | Analysts=5
EPS current Year (2026-12-31): EPS=1.01 | Chg30d=+2.85% | Revisions=+50% | GrowthEPS=+17.4% | GrowthRev=+15.5%
EPS next Year (2027-12-31): EPS=1.13 | Chg30d=+1.07% | Revisions=+20% | GrowthEPS=+12.1% | GrowthRev=+20.3%
[Analyst] Revisions Ratio: +50%